Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-05T11:59:07.580Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychiatric Comorbidity in 36 Adults with Mitochondrial Cytopathies

Published online by Cambridge University Press:  07 November 2014

Omar Fattal ,
Jessica Link ,
Kathleen Quinn ,
Bruce H. Cohen  and
Kathleen Franco
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Mitochondria are intracellular organelles involved in adenosine triphosphate production. The literature has established the presence of mitochondrial dysfunction in some subjects with psychiatric disorders. Also, there are multiple reports of patients with mitochondrial dysfunction who have various psychiatric disorders. Although the literature on mitochondrial dysfunction and its relation to psychiatric disorders is growing, there remain many unanswered questions.

Objective:

To review subjects with mitochondrial cytopathies for prevalence of psychiatric comorbidity.

Methods:

For this study, 36 adults were interviewed. The Mini International Neuropsychiatric Interview and the Short-Form 36 Health Survey, version 1 were used.

Results:

Lifetime diagnoses included 54% major depressive disorder, 17% bipolar disorder, and 11% panic disorder. These prevalence rates are compared with the general population and subjects with cancer and epilepsy. Subjects with a comorbid psychiatric diagnosis were older (P=.05), had more hospital admissions (P=.02), more medical conditions (P=.01), and lower quality of life (P=.01) than subjects with mitochondrial disease alone.

Conclusion:

Clinicians caring for persons with mitochondrial cytopathies should note the high prevalence of psychiatric problems. Also, this comorbidity might have etiological and therapeutic implications.

Type
Original Research
Information
CNS Spectrums , Volume 12 , Issue 6 , June 2007 , pp. 429 - 438
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Antozzi, C, Uziel, G, Mariotti, C, Rimoldi, M, Di Donate, S, Zeviani, M. Mitochondrial encephalomyopathies. In: Di Donate, S, Parini, R, Uziel, G, eds. Metabolic Encephalopathies Therapy and Prognosis. Mariani Foundation Pediatric Neurology. series: 4. London, England: John Libbey & Company, Ltd; 1995:25–36.Google Scholar
2.Cohen, BH, Gold, DR. Mitochondrial cytopathy in adults. What we know so far. Cleve Clin J Med 2001;68:625–626, 629–642.CrossRefGoogle ScholarPubMed
3.Dimauro, S, Tay, S, Mancuso, M. Mitochondrial encephalomyopathies. Diagnostic approach. Ann N Y Acad Sci. 2004;1011:217–231.Google Scholar
4.Gold, DR, Cohen, B. Treatment of Mitochondrial Cytopathies. Semin Neurol. 2001;21:309–325.CrossRefGoogle ScholarPubMed
5.Taivassalo, T, Haller, RG. Implications of exercise training in mtDNA defects—use it or lose it?Biochem Biophys Acta. 2004;1659:221–231.Google Scholar
6.Kato, T, Takahashi, Y. Deletion of leukocyte mitochondrial DNA in bipolar disorder. J Affect Disord 1996;37:67–73.CrossRefGoogle ScholarPubMed
7.Konradi, C, Eaton, M, MacDonald, ML, Walsh, J, Benes, FM, Heckers, S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry. 2004;61:300–308.CrossRefGoogle ScholarPubMed
8.Kung, L, Roberts, RC. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse. 1999;31:67–75.3.0.CO;2-#>CrossRefGoogle ScholarPubMed
9.Ben-Shachar, D, Laifenfeld, D. Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol. 2004;59:273–296.CrossRefGoogle ScholarPubMed
10.Prince, JA, Harro, J, Blennow, K, Gottfries, CG, Oreland, L. Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics. Neuropsychopharmacology. 2000;22:284–292.CrossRefGoogle ScholarPubMed
11.Onishi, H, Kawanishi, C, Iwasawa, T, et al.Depressive disorder due to mitochondrial transfer RNA Leu (UUR) mutation. Biol Psychiatry. 1997;41:1137–1139.CrossRefGoogle Scholar
12.Miyaoka, H, Suzuki, Y, Taniyama, M, et al.Mental disorders in diabetic patients with mitochondrial transfer RNA Leu (UUR) mutation at position 3243. Biol Psychiatry. 1997;42:524–526.CrossRefGoogle ScholarPubMed
13.Suomalainen, A, Majander, A, Haltia, M, at al.Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest. 1992;90:61–66.CrossRefGoogle ScholarPubMed
14.Gardner, A, Pagani, M, Wibom, R, Nennesmo, I, Jacobsson, H, Hallstrom, T. Alterations of rCBF and mitochondrial dysfunction in major depressive disorder: a case report. Acta Psychiatr Scand. 2003;107:233–239.CrossRefGoogle ScholarPubMed
15.Jaksch, M, Lochmuler, H, Schmitt, F, Volpel, B, Obermaier-Kusser, B, Horvath, RA. Mutation in mt tRNALeu(UUR) causing a neuropsychiatric syndrome with depression and cataract. Neurology. 2001;57:1930–1931.CrossRefGoogle ScholarPubMed
16.Stewart, JB, Naylor, GJ. Manic-depressive psychosis in a patient with mitochondrial myopathy: a case report. Med Sci Res. 1990;18:265–266.Google Scholar
17.Suzuki, T, Koizumi, J, Shiraishi, H, et al.Mitochondrial encephalomyopathy (MELAS) with mental disorder CT, MRI and SPECT findings. Neuroradiology. 1990;32:74–76.CrossRefGoogle ScholarPubMed
18.Kiejna, A, DiMauro, S, Adamowski, T, Rymaszewska, J, Leszek, J, Pachalska, M. Psychiatric symptoms in a patient with the clinical features of MELAS. Med Sci Monit. 2002;8:CS66–CS72.Google Scholar
19.Odawara, M, Isaka, M, Tada, K, Mizusawa, H, Yamashita, K. Diabetes mellitus associated with mitochondrial myopathy and schizophrenia: a possible link between diabetes mellitus and schizophrenia. Diabet Med. 1997;14:503–504.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
20.Amemiya, S, Hamamoto, M, Goto, Y, et al.Psychosis and progressing dementia: presenting features of a mitochondriopathy. Neurology. 2000;55:600–601.CrossRefGoogle ScholarPubMed
21.Saijo, T, Naito, E, Ito, M, Takeda, E, Hashimoto, T, Kuroda, Y. Therapeutic effects of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics. 1991;22:166–167.CrossRefGoogle Scholar
22.Inagaki, T, Ishino, H, Seno, H, Ohguni, S, Tanaka, J, Kato, Y. Psychiatric symptoms in a patient with diabetes mellitus associated with point mutation in mitochondrial DNA. Biol Psychiatry. 1997;42:1067–1069.CrossRefGoogle Scholar
23.Thomeer, EC, Verhoeven, WM, Van de Vlasakker, CJ, Klompenhouwer, JL. Psychiatric symptoms in MELAS: a case report. J Neurol Neurosurg Psychiatry. 1998;64:692–693.CrossRefGoogle ScholarPubMed
24.Spellberg, B, Carroll, R, Robinson, E, Brass, E. mtDNA disease in the primary care setting. Arch Intern Med 2001;161:2497–2500.CrossRefGoogle ScholarPubMed
25.Koller, H, Kornischka, J, Neuen-Jacob, E, et al.Persistent organic personality change as rare psychiatric manifestation of MELAS syndrome. J Neurol. 2003;250:1501–1502.CrossRefGoogle ScholarPubMed
26.Gardner, A, Boles, RG. Is a “mitochondrial psychiatry” in the future? A review. Curr Psych Rev. 2005;1:257–272.Google Scholar
27.Varvogli, L, Waisbren, SE. Personality profiles of mothers of children with mitochondrial disorders. J Inher Metab Dis. 1999;22:615–622.CrossRefGoogle ScholarPubMed
28.Boles, RG, Burnett, BB, Gleditsch, K, et al.A high predisposition to depression and anxiety in mothers and other matrilineal relatives of children with presumed maternally inherited mitochondrial disorders. Am J Med Genet B Neuropsychiatr Genet. 2005;137:20–24.CrossRefGoogle Scholar
29.Bernier, FP, Boneh, A, Dennett, X, Chow, CW, Cleary, MA, Thorburn, DR. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology. 2002;59:1406–1411.CrossRefGoogle ScholarPubMed
30.Folstein, MF, Folstein, SE, McHugh, PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.CrossRefGoogle ScholarPubMed
31.Sheehan, DV, Lecrubier, Y, Harnett-Sheehan, K, et al.The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22–33.Google ScholarPubMed
32.Ware, JE, Sherbourne, CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473–483.CrossRefGoogle ScholarPubMed
33.Statistical Analysis System (SAS). version 9.1. Cary, NC: SAS Institute Incorporated: 2002–2003.Google Scholar
34.Ware, JE, Kosinski, M, Gandek, B. SF-36® Health Survey Manual and Interpretation Guide. Lincoln, RI: QualityMetric Inc; 2004.Google Scholar
35.Roy, AK, Rajesh, SV, Iby, N, Jose, JM, Sarma, GR. A study of epilepsy-related psychosis. Neurol India. 2003;51:359–360.Google ScholarPubMed
36.Sadock, BJ, Sadock, AS, eds. Kaplan and Sadock's Synopsis of Psychiatry. 9th ed. Philadelphia, Penn: Williams & Wilkins; 2003:535, 599.Google Scholar
37.Katon, W, Ciechanowski, P. Impact of major depression on chronic medical illness. J Psychosom Res. 2002;53:859–863.CrossRefGoogle ScholarPubMed
38.Derogatis, L, Morrow, G, Fetting, J, et al.The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751–757.CrossRefGoogle ScholarPubMed
39.Jones, JE, Hermann, BP, Barry, JJ, Gilliam, F, Kanner, AM, Meader, KJ. Clinical assessment of axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci. 2005;17:172–179.CrossRefGoogle ScholarPubMed